Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 63 | 2023 | 5181 | 3.590 |
Why?
|
p21-Activated Kinases | 2 | 2018 | 128 | 1.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2023 | 8428 | 0.960 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 3 | 2018 | 86 | 0.850 |
Why?
|
Sp1 Transcription Factor | 2 | 2014 | 144 | 0.840 |
Why?
|
Waldenstrom Macroglobulinemia | 5 | 2021 | 1052 | 0.790 |
Why?
|
Acrylamides | 3 | 2018 | 255 | 0.690 |
Why?
|
Transcriptional Activation | 3 | 2014 | 1783 | 0.570 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 105 | 0.560 |
Why?
|
Mice, SCID | 19 | 2018 | 2716 | 0.560 |
Why?
|
Cell Line, Tumor | 29 | 2023 | 16689 | 0.510 |
Why?
|
Cell Survival | 13 | 2018 | 5882 | 0.510 |
Why?
|
Aminopyridines | 1 | 2018 | 542 | 0.500 |
Why?
|
Cell Proliferation | 21 | 2023 | 10481 | 0.500 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1341 | 0.440 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 973 | 0.420 |
Why?
|
Antineoplastic Agents | 11 | 2023 | 13695 | 0.400 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2014 | 571 | 0.350 |
Why?
|
Plasma Cells | 4 | 2018 | 591 | 0.340 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5867 | 0.330 |
Why?
|
Oncogenes | 4 | 2021 | 1265 | 0.320 |
Why?
|
RNA Splicing | 3 | 2019 | 907 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2018 | 3557 | 0.300 |
Why?
|
Apoptosis | 14 | 2022 | 9727 | 0.290 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2018 | 299 | 0.290 |
Why?
|
Cytokines | 4 | 2018 | 7322 | 0.280 |
Why?
|
Leukocytes, Mononuclear | 4 | 2023 | 1836 | 0.270 |
Why?
|
Mice | 35 | 2023 | 81183 | 0.270 |
Why?
|
Translocation, Genetic | 4 | 2021 | 1420 | 0.270 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1676 | 0.270 |
Why?
|
Bone Marrow Cells | 8 | 2017 | 2513 | 0.260 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2023 | 1338 | 0.260 |
Why?
|
Rad51 Recombinase | 2 | 2018 | 189 | 0.260 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9274 | 0.240 |
Why?
|
Cell Cycle | 2 | 2011 | 2967 | 0.230 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 140 | 0.230 |
Why?
|
Immunotherapy | 2 | 2009 | 4445 | 0.230 |
Why?
|
B-Lymphocytes | 2 | 2016 | 4665 | 0.230 |
Why?
|
MicroRNAs | 4 | 2023 | 3752 | 0.220 |
Why?
|
Stem Cell Transplantation | 3 | 2022 | 1620 | 0.220 |
Why?
|
Dexamethasone | 7 | 2023 | 1951 | 0.220 |
Why?
|
Syndecan-1 | 2 | 2017 | 165 | 0.220 |
Why?
|
Osteoclasts | 5 | 2013 | 729 | 0.220 |
Why?
|
Interleukin-6 | 5 | 2012 | 3200 | 0.220 |
Why?
|
DNA Damage | 4 | 2018 | 2432 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.210 |
Why?
|
Animals | 38 | 2023 | 168757 | 0.210 |
Why?
|
Hydroxamic Acids | 3 | 2016 | 494 | 0.210 |
Why?
|
Boronic Acids | 6 | 2013 | 965 | 0.210 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.210 |
Why?
|
RNA, Small Interfering | 7 | 2017 | 3505 | 0.210 |
Why?
|
Caspases | 5 | 2018 | 928 | 0.200 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2133 | 0.190 |
Why?
|
Bone Marrow | 8 | 2021 | 2948 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11524 | 0.190 |
Why?
|
Pyrazines | 6 | 2013 | 1230 | 0.190 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2023 | 671 | 0.180 |
Why?
|
Tumor Cells, Cultured | 9 | 2020 | 6314 | 0.170 |
Why?
|
14-3-3 Proteins | 1 | 2020 | 214 | 0.170 |
Why?
|
Transcription Factor DP1 | 1 | 2018 | 141 | 0.170 |
Why?
|
STAT3 Transcription Factor | 3 | 2014 | 873 | 0.170 |
Why?
|
NAD | 2 | 2013 | 593 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2023 | 5172 | 0.160 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 190 | 0.160 |
Why?
|
Heavy Chain Disease | 1 | 2018 | 19 | 0.160 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2018 | 62 | 0.160 |
Why?
|
Stromal Cells | 8 | 2012 | 1355 | 0.160 |
Why?
|
Immunologic Factors | 2 | 2023 | 1580 | 0.160 |
Why?
|
Prognosis | 5 | 2018 | 29063 | 0.160 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3586 | 0.160 |
Why?
|
Humans | 71 | 2023 | 744343 | 0.160 |
Why?
|
RNA Precursors | 1 | 2019 | 208 | 0.160 |
Why?
|
Nuclear Factor 45 Protein | 1 | 2017 | 5 | 0.160 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2018 | 417 | 0.150 |
Why?
|
Alternative Splicing | 1 | 2022 | 1117 | 0.150 |
Why?
|
Polyadenylation | 1 | 2018 | 117 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.150 |
Why?
|
bcl-X Protein | 1 | 2018 | 411 | 0.150 |
Why?
|
Interleukin-17 | 2 | 2015 | 899 | 0.150 |
Why?
|
Thalidomide | 3 | 2019 | 890 | 0.150 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1537 | 0.140 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2085 | 0.140 |
Why?
|
Protein Binding | 3 | 2018 | 9386 | 0.140 |
Why?
|
Azepines | 1 | 2018 | 336 | 0.140 |
Why?
|
Osteoblasts | 4 | 2013 | 1166 | 0.140 |
Why?
|
RNA Interference | 2 | 2018 | 2889 | 0.140 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 1941 | 0.140 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 177 | 0.140 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2017 | 374 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3703 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2011 | 789 | 0.130 |
Why?
|
Histone Deacetylases | 3 | 2016 | 728 | 0.130 |
Why?
|
Oligonucleotides, Antisense | 1 | 2018 | 433 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 1434 | 0.130 |
Why?
|
Gene Expression Profiling | 9 | 2018 | 9438 | 0.130 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.130 |
Why?
|
Polymers | 1 | 2023 | 1621 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2012 | 480 | 0.130 |
Why?
|
Paraproteinemias | 1 | 2018 | 246 | 0.130 |
Why?
|
Allosteric Regulation | 1 | 2017 | 408 | 0.130 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 769 | 0.130 |
Why?
|
Introns | 1 | 2018 | 991 | 0.130 |
Why?
|
Cyclophilin A | 1 | 2015 | 57 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2012 | 489 | 0.130 |
Why?
|
Oligonucleotides | 1 | 2018 | 572 | 0.130 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 140 | 0.130 |
Why?
|
Oligopeptides | 1 | 2020 | 1189 | 0.120 |
Why?
|
Antibodies | 2 | 2017 | 2460 | 0.120 |
Why?
|
Protein Subunits | 1 | 2018 | 959 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1266 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2015 | 1526 | 0.120 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 594 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2014 | 2455 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2018 | 970 | 0.120 |
Why?
|
Cell Death | 3 | 2014 | 1706 | 0.110 |
Why?
|
Melphalan | 3 | 2023 | 431 | 0.110 |
Why?
|
Triazoles | 1 | 2018 | 911 | 0.110 |
Why?
|
Sirtuins | 1 | 2015 | 323 | 0.110 |
Why?
|
Cell Adhesion | 5 | 2011 | 3144 | 0.110 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2018 | 685 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1270 | 0.100 |
Why?
|
Flow Cytometry | 2 | 2021 | 5974 | 0.100 |
Why?
|
Alleles | 2 | 2021 | 6933 | 0.100 |
Why?
|
Osteolysis | 2 | 2012 | 270 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1813 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3870 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 893 | 0.100 |
Why?
|
MAP Kinase Kinase 2 | 2 | 2010 | 96 | 0.100 |
Why?
|
beta Catenin | 2 | 2015 | 1059 | 0.100 |
Why?
|
Genomics | 4 | 2019 | 5720 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 229 | 0.090 |
Why?
|
Mice, Nude | 1 | 2017 | 3689 | 0.090 |
Why?
|
Piperidines | 3 | 2013 | 1602 | 0.090 |
Why?
|
Remission Induction | 1 | 2015 | 2386 | 0.090 |
Why?
|
SUMO-1 Protein | 1 | 2009 | 35 | 0.090 |
Why?
|
Cell Movement | 5 | 2016 | 5217 | 0.090 |
Why?
|
Neuroblastoma | 1 | 2018 | 1226 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1861 | 0.090 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2010 | 337 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2009 | 71 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3494 | 0.080 |
Why?
|
Maytansine | 1 | 2009 | 80 | 0.080 |
Why?
|
Gene Targeting | 1 | 2012 | 880 | 0.080 |
Why?
|
Activins | 1 | 2010 | 208 | 0.080 |
Why?
|
Survival Rate | 6 | 2021 | 12788 | 0.080 |
Why?
|
Plasmids | 1 | 2014 | 2307 | 0.080 |
Why?
|
Transcription Factors | 5 | 2015 | 12208 | 0.080 |
Why?
|
Quinazolinones | 1 | 2010 | 221 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 625 | 0.080 |
Why?
|
NF-kappa B | 2 | 2014 | 2499 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2022 | 6895 | 0.080 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 697 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 561 | 0.080 |
Why?
|
Niacinamide | 1 | 2010 | 417 | 0.080 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.080 |
Why?
|
Signal Transduction | 7 | 2021 | 23403 | 0.080 |
Why?
|
Transplantation, Autologous | 2 | 2023 | 2124 | 0.080 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 119 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2183 | 0.070 |
Why?
|
Drug Synergism | 4 | 2016 | 1792 | 0.070 |
Why?
|
Enzyme Inhibitors | 3 | 2012 | 3798 | 0.070 |
Why?
|
Etodolac | 1 | 2006 | 20 | 0.070 |
Why?
|
Purines | 1 | 2010 | 594 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.070 |
Why?
|
Cytotoxins | 1 | 2007 | 153 | 0.070 |
Why?
|
Cell Differentiation | 5 | 2015 | 11483 | 0.070 |
Why?
|
Catechin | 1 | 2006 | 66 | 0.070 |
Why?
|
Immunoblotting | 4 | 2012 | 1682 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 624 | 0.060 |
Why?
|
Mutation | 7 | 2021 | 29786 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 3023 | 0.060 |
Why?
|
Bone Regeneration | 1 | 2008 | 427 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 986 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2009 | 1663 | 0.060 |
Why?
|
Phosphorylation | 3 | 2010 | 8436 | 0.060 |
Why?
|
GTP Phosphohydrolases | 2 | 2020 | 509 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2008 | 791 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1758 | 0.060 |
Why?
|
Male | 19 | 2021 | 350118 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2014 | 1423 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1403 | 0.060 |
Why?
|
Proteins | 2 | 2023 | 6103 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9648 | 0.060 |
Why?
|
Acetylation | 2 | 2016 | 1085 | 0.060 |
Why?
|
Disease Progression | 3 | 2022 | 13284 | 0.060 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 1978 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2009 | 1366 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2942 | 0.050 |
Why?
|
Osteogenesis | 1 | 2009 | 1299 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1583 | 0.050 |
Why?
|
Benzimidazoles | 1 | 2007 | 850 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2009 | 901 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 1972 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1990 | 0.050 |
Why?
|
Membrane Proteins | 5 | 2021 | 7880 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2012 | 3701 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4186 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 2938 | 0.050 |
Why?
|
Doxorubicin | 2 | 2018 | 2234 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2006 | 996 | 0.050 |
Why?
|
Pyrimidines | 1 | 2012 | 2942 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2013 | 19229 | 0.040 |
Why?
|
Kinetics | 2 | 2018 | 6473 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1621 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2126 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 220 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 279 | 0.040 |
Why?
|
Genetic Vectors | 2 | 2021 | 3420 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 377 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2915 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2575 | 0.040 |
Why?
|
Down-Regulation | 3 | 2012 | 3002 | 0.040 |
Why?
|
Chromatin | 2 | 2023 | 2934 | 0.040 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2018 | 23 | 0.040 |
Why?
|
Transplantation, Heterologous | 4 | 2007 | 2382 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 440 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2012 | 0.040 |
Why?
|
Ubiquitin | 1 | 2023 | 852 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3920 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2021 | 913 | 0.040 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2017 | 40 | 0.040 |
Why?
|
Multiprotein Complexes | 2 | 2015 | 1119 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2013 | 2505 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 63114 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2018 | 295 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 457 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2008 | 1632 | 0.040 |
Why?
|
DNA Repair | 2 | 2017 | 2046 | 0.040 |
Why?
|
Gene Expression | 3 | 2018 | 7799 | 0.040 |
Why?
|
Sequence Analysis, Protein | 1 | 2018 | 258 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2006 | 2107 | 0.040 |
Why?
|
Exons | 1 | 2022 | 2437 | 0.040 |
Why?
|
Female | 15 | 2021 | 380194 | 0.040 |
Why?
|
Genes, myc | 1 | 2018 | 399 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 666 | 0.040 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2015 | 43 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2018 | 513 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 684 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2012 | 1341 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2219 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1074 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 168 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4751 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2018 | 377 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1801 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
Autophagy | 2 | 2013 | 1300 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1692 | 0.030 |
Why?
|
Lymphotoxin-beta | 1 | 2014 | 12 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2023 | 1903 | 0.030 |
Why?
|
Blotting, Western | 2 | 2013 | 5179 | 0.030 |
Why?
|
Point Mutation | 1 | 2019 | 1623 | 0.030 |
Why?
|
Genomic Instability | 1 | 2018 | 695 | 0.030 |
Why?
|
Early Growth Response Protein 1 | 1 | 2014 | 140 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3647 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1878 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1252 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.030 |
Why?
|
Gene Amplification | 1 | 2018 | 1063 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2023 | 5021 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2274 | 0.030 |
Why?
|
Sulfonamides | 1 | 2022 | 1938 | 0.030 |
Why?
|
DNA Replication | 1 | 2019 | 1399 | 0.030 |
Why?
|
Cell Line | 3 | 2013 | 15997 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.030 |
Why?
|
Aged | 7 | 2020 | 163280 | 0.030 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 140 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18029 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1708 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2803 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2503 | 0.030 |
Why?
|
Benzoquinones | 1 | 2012 | 201 | 0.020 |
Why?
|
Integrin alpha4 | 1 | 2011 | 92 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 149 | 0.020 |
Why?
|
Neovascularization, Pathologic | 2 | 2012 | 2635 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2309 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 130 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 1007 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2013 | 13033 | 0.020 |
Why?
|
Ligands | 2 | 2009 | 3282 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 399 | 0.020 |
Why?
|
Middle Aged | 7 | 2020 | 213383 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 428 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 557 | 0.020 |
Why?
|
Adult | 6 | 2022 | 214055 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 320 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9583 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2077 | 0.020 |
Why?
|
Androstadienes | 1 | 2012 | 346 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.020 |
Why?
|
Receptors, Interleukin-17 | 1 | 2010 | 69 | 0.020 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2009 | 33 | 0.020 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 233 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2010 | 156 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2010 | 433 | 0.020 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2009 | 72 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 1246 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 158 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3508 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6114 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 356 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 452 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2038 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 970 | 0.020 |
Why?
|
Fibronectins | 1 | 2011 | 726 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2007 | 143 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 2008 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1832 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 936 | 0.020 |
Why?
|
Receptors, Laminin | 1 | 2006 | 26 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2007 | 162 | 0.020 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2007 | 193 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7722 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.020 |
Why?
|
Lentivirus | 1 | 2009 | 501 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2010 | 890 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2006 | 201 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 225 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1009 | 0.020 |
Why?
|
RANK Ligand | 1 | 2007 | 326 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2599 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2006 | 277 | 0.020 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2004 | 38 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1057 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2004 | 27 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1940 | 0.020 |
Why?
|
Syndecans | 1 | 2004 | 79 | 0.020 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2004 | 57 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2715 | 0.020 |
Why?
|
Tea | 1 | 2006 | 275 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2004 | 91 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2564 | 0.020 |
Why?
|
RNA | 1 | 2014 | 2749 | 0.020 |
Why?
|
Phytotherapy | 1 | 2006 | 298 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.010 |
Why?
|
Bone Marrow Neoplasms | 1 | 2004 | 104 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 2004 | 101 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2009 | 1284 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 2004 | 434 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2109 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5853 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1726 | 0.010 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2008 | 496 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 72290 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3036 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 2015 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2009 | 4776 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 835 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2006 | 1157 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4462 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5892 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2004 | 1369 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2421 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2866 | 0.010 |
Why?
|
DNA | 1 | 2014 | 7301 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13815 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4409 | 0.010 |
Why?
|
Neoplasms | 1 | 2009 | 21683 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4217 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18111 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12261 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3748 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3479 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4456 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4149 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3567 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6489 | 0.010 |
Why?
|
Antigens, CD | 1 | 2004 | 4026 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3768 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6773 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 40561 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 21827 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 77449 | 0.010 |
Why?
|